Steve Schonfeld Schonfeld Strategic Advisors
Steve Schonfeld is the founder of Schonfeld Strategic Advisors, a multi-manager investment firm with roots in proprietary trading. Schonfeld allocates capital across quantitative and discretionary strategies with an emphasis on risk controls and diversification of return streams. The firm is a major name in the multi-strategy hedge fund landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NRG Energy
NRG
|
+$61.4M |
| 2 |
Vistra
VST
|
+$60.2M |
| 3 |
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
|
+$44.4M |
| 4 |
ConocoPhillips
COP
|
+$33.8M |
| 5 |
ETFC
E*Trade Financial Corporation
ETFC
|
+$32.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Conagra Brands
CAG
|
+$43.5M |
| 2 |
Target
TGT
|
+$30.5M |
| 3 |
Best Buy
BBY
|
+$28.2M |
| 4 |
Canadian Natural Resources
CNQ
|
+$23.9M |
| 5 |
APU
AmeriGas Partners, L.P.
APU
|
+$20M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.72% |
| 2 | Financials | 15.54% |
| 3 | Consumer Discretionary | 11.37% |
| 4 | Technology | 11.07% |
| 5 | Energy | 9.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AVLR
326
DELISTED
Avalara, Inc.
AVLR
| $1.69M | 0.06% |
+23,392
| New | +$1.51M |
|
327
Cadence Design Systems
CDNS
$86.2B
| $1.67M | 0.06% |
23,637
+2,037
| +9% | +$136K |
|
328
Analog Devices
ADI
$179B
| $1.66M | 0.06% |
14,714
+1,814
| +14% | +$197K |
|
|
NSTG
329
DELISTED
NanoString Technologies, Inc.
NSTG
| $1.66M | 0.06% |
54,700
-119,300
| -69% | -$3.16M |
|
330
Charles River Laboratories
CRL
$14.1B
| $1.66M | 0.06% |
11,700
-27,108
| -70% | -$3.68M |
|
331
Myriad Genetics
MYGN
$293M
| $1.65M | 0.06% |
59,400
-44,054
| -43% | -$1.24M |
|
332
Goodyear
GT
$1.71B
| $1.64M | 0.06% |
+107,200
| New | +$1.81M |
|
333
RH
RH
$2.71B
| $1.64M | 0.06% |
+14,154
| New | +$1.46M |
|
|
AXNX
334
DELISTED
Axonics, Inc. Common Stock
AXNX
| $1.63M | 0.06% |
39,900
+15,000
| +60% | +$422K |
|
335
OrthoPediatrics
KIDS
$665M
| $1.63M | 0.06% |
41,800
-63,500
| -60% | -$2.56M |
|
336
Starbucks
SBUX
$123B
| $1.62M | 0.06% |
+19,364
| New | +$1.52M |
|
337
Guardant Health
GH
$22.4B
| $1.61M | 0.06% |
+18,700
| New | +$1.43M |
|
338
Synopsys
SNPS
$74.8B
| $1.61M | 0.06% |
+12,537
| New | +$1.51M |
|
339
Zillow
Z
$8.22B
| $1.59M | 0.06% |
34,232
-5,300
| -13% | -$211K |
|
|
LLL
340
DELISTED
L3 Technologies, Inc.
LLL
| $1.59M | 0.06% |
6,479
+2,479
| +62% | +$579K |
|
341
Netflix
NFLX
$334B
| $1.58M | 0.06% |
43,000
-87,000
| -67% | -$3.14M |
|
342
Zimmer Biomet
ZBH
$19.3B
| $1.58M | 0.06% |
14,832
-20,291
| -58% | -$2.38M |
|
|
TSS
343
DELISTED
Total System Services, Inc.
TSS
| $1.58M | 0.06% |
12,298
-80,249
| -87% | -$8.82M |
|
344
Avient
AVNT
$4.06B
| $1.57M | 0.06% |
49,900
+29,449
| +144% | +$825K |
|
345
Artivion
AORT
$1.33B
| $1.56M | 0.06% |
52,200
-190,700
| -79% | -$5.66M |
|
346
Ameriprise Financial
AMP
$49.4B
| $1.54M | 0.05% |
10,578
-36,923
| -78% | -$5.34M |
|
347
Merit Medical Systems
MMSI
$5.4B
| $1.52M | 0.05% |
25,600
+3,900
| +18% | +$224K |
|
|
DOO
348
Bombardier Recreational Products
DOO
$4.75B
| $1.52M | 0.05% |
+42,600
| New | +$1.33M |
|
349
Linde
LIN
$224B
| $1.51M | 0.05% |
7,537
-14,463
| -66% | -$2.71M |
|
350
Carter's
CRI
$1.27B
| $1.51M | 0.05% |
15,500
+12,763
| +466% | +$1.24M |
|
Similar funds
Steve Schonfeld's Q2 2019 Portfolio in Review
As of Q2 2019, Steve Schonfeld held 1,400 positions worth $2.83B, down 1.8% from $2.88B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Steve Schonfeld withdrew a net $96.1M in Q2 2019, closing 442 positions and reducing 316 holdings. Its most notable exit was Conagra Brands, an estimated $43.5M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 21% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Steve Schonfeld opened a new position in Equitrans Midstream Corporation Common Stock worth $42.1M.
- Steve Schonfeld's largest Q2 2019 buy was Equitrans Midstream Corporation Common Stock: 2,136,064 shares worth $42.1M.
- Steve Schonfeld added most to NRG Energy in Q2 2019, an estimated $61.4M increase.
- Steve Schonfeld's biggest Q2 2019 reduction was Target, cutting an estimated $30.5M.
- Steve Schonfeld fully exited Conagra Brands in Q2 2019, selling an estimated $43.5M.
- Steve Schonfeld's ten largest holdings make up 16% of its $2.83B portfolio in Q2 2019.
- Steve Schonfeld opened 374 new positions and closed 442 in Q2 2019.
- Steve Schonfeld's portfolio value fell 1.8% quarter-over-quarter to $2.83B.
Based on Schonfeld Strategic Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.